PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - Le Heuzey, Jean-Yves
TI  - Anticoagulation and Antithrombotic Therapy in Atrial Fibrillation
DP  - 2012 Nov 01
TA  - MD Conference Express
PG  - 32--33
VI  - 12
IP  - 13
4099  - http://mdc.sagepub.com/content/12/13/32.short
4100  - http://mdc.sagepub.com/content/12/13/32.full
AB  - Patients with atrial fibrillation (AF) have a 5-fold risk of stroke and suffer more severe strokes compared with the general population [Camm AJ et al. Eur Heart J 2010]. One-year mortality in stroke patients with AF is 63% versus 34% in those without AF (p<0.001) [Lin H-J et al. Stroke 1996]. The risk of stroke recurrence is slightly higher in patients with AF (6.9% vs 4.7% in those without AF; p=0.0398) [Marini C et al. Stroke 2005].